
Caribou Biosciences Inc
NASDAQ:CRBU

Intrinsic Value
The intrinsic value of one
CRBU
stock under the Base Case scenario is
2.06
USD.
Compared to the current market price of 1.09 USD,
Caribou Biosciences Inc
is
Undervalued by 47%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Caribou Biosciences Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Caribou Biosciences Inc
Balance Sheet Decomposition
Caribou Biosciences Inc
Current Assets | 217.3m |
Cash & Short-Term Investments | 208.5m |
Receivables | 2.7m |
Other Current Assets | 6.1m |
Non-Current Assets | 56.3m |
Long-Term Investments | 13.3m |
PP&E | 38m |
Other Non-Current Assets | 5m |
Free Cash Flow Analysis
Caribou Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Caribou Biosciences Inc
Revenue
|
9.9m
USD
|
Operating Expenses
|
-173.4m
USD
|
Operating Income
|
-163.5m
USD
|
Other Expenses
|
15.7m
USD
|
Net Income
|
-147.9m
USD
|
CRBU Profitability Score
Profitability Due Diligence
Caribou Biosciences Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

Score
Caribou Biosciences Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
CRBU Solvency Score
Solvency Due Diligence
Caribou Biosciences Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Score
Caribou Biosciences Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRBU Price Targets Summary
Caribou Biosciences Inc
Dividends
Current shareholder yield for CRBU is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CRBU
stock under the Base Case scenario is
2.06
USD.
Compared to the current market price of 1.09 USD,
Caribou Biosciences Inc
is
Undervalued by 47%.